SCHEMBL2802479

SCHEMBL2802479

CCCCCCCCCCCC(C)(C)OC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.57
BCL9 O00512 1/20 0.52
CTNNB1 P35222 1/20 0.52
GAA P10253 1/20 0.45
HTR2A P28223 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
FAAH O00519 1/20 0.41
TBXA2R P21731 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL763093 0.88 BCL9 (0.54) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL13073179 0.86 BCL9 (0.47) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL6359040 0.84 BCL9 (0.56) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL13033883 0.84 BCL9 (0.45) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL15486850 0.82 BCL9 (0.48) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL25645511 0.82 NPC1 (0.43) MGLLALDH1A1MAPTNPC1RAB9A
SCHEMBL19315980 0.81 BCL9 (0.48) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL903436 0.81 BCL9 (0.52) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL19112643 0.81 BCL9 (0.47) MGLLBCL9CTNNB1GAAHTR2A
SCHEMBL15491284 0.81 GAA (0.49) MGLLBCL9CTNNB1GAAHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183603-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION 2023-06-15 US disclosed
US-20230183603-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION 2023-06-15 US disclosed
US-11624041-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2023-04-11 US disclosed
US-20200263110-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION 2020-08-20 US disclosed
US-10626349-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2020-04-21 US disclosed
US-20180187127-A1 CLEAVABLE SURFACTANTS JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT 2018-07-05 US disclosed
US-9816054-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2017-11-14 US disclosed
US-9816054-B2 Cleavable surfactants PROMEGA CORPORATION (US) 2017-11-14 US disclosed
EP-2584027-B1 Cleavable surfactants PROMEGA CORP (US) 2015-12-30 EP disclosed
EP-2584027-B1 Cleavable surfactants PROMEGA CORP (US) 2015-12-30 EP disclosed
EP-2584027-A2 Cleavable surfactants Promega Corporation (US) 2013-04-24 EP disclosed
EP-2584027-A2 Cleavable surfactants Promega Corporation (US) 2013-04-24 EP disclosed
EP-2197996-B1 CLEAVABLE SURFACTANTS PROMEGA CORP (US) 2012-12-05 EP disclosed
EP-2197996-B1 CLEAVABLE SURFACTANTS PROMEGA CORP (US) 2012-12-05 EP disclosed
EP-2197996-A2 CLEAVABLE SURFACTANTS Promega Corporation (US) 2010-06-23 EP disclosed
WO-2009048611-A2 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 WO disclosed
WO-2009048611-A2 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 WO disclosed
US-20090095628-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 US disclosed
US-20090095628-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 US disclosed
US-20090095628-A1 CLEAVABLE SURFACTANTS PROMEGA CORPORATION (US) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200263110-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 MGLL 276/4885BCL9 1442/4885CTNNB1 3850/4885
US-11624041-B2 Cleavable surfactants SI, PRSS3, TMPRSS15 MGLL 276/4885BCL9 1442/4885CTNNB1 3850/4885
US-20180187127-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 MGLL 276/4885BCL9 1442/4885CTNNB1 3850/4885
US-10626349-B2 Cleavable surfactants SI, PRSS3, TMPRSS15 MGLL 276/4885BCL9 1442/4885CTNNB1 3850/4885
US-20090095628-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 MGLL 276/4885BCL9 1442/4885CTNNB1 3850/4885
US-20230183603-A1 CLEAVABLE SURFACTANTS SI, PRSS3, TMPRSS15 MGLL 276/4885BCL9 1442/4885CTNNB1 3850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.